The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective: a review
The DOI matches its Crossref record; 119 of the 120 references it cites were found in a registry or an index.
Abstract
Side effects are among the most frequent reasons preventing patients from taking their medication. Although the management of side effects is an important issue in clinical practice, particularly in patients with physical comorbidities, research on clinical management of side effects is rather scattered. The aim of this article was to provide an overview on the prevalence and management of various side effects of mood-stabilizing drugs. In December 2012, we carried out a PubMed search for publications reporting side effects in patients with bipolar disorder. Naturalistic studies describing the prevalence of side effects in treatment with mood stabilizers are sparse. We describe the prevalence of neurological, gastrointestinal, metabolic, thyroid, dermatological, nephrogenic, cognitive, sexual, hematological, hepatogenic, and teratogenic side effects of lithium, valproate, carbamazepine, and lamotrigine and discuss their clinical management. There are specific strategies that aim at reducing side effects, but, to date, studies on the efficacy of these interventions are lacking. With age, the renal elimination and hepatic metabolism of drugs reduce and comedication and somatic comorbidity increase, making elderly patients particularly susceptible to side effects. Most side effects can be managed by striving for the lowest possible dose without losing efficacy by lowering the dose below the therapeutic window. Specific measurements to limit certain side effects are available and may ameliorate treatment adherence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Carbamazepine induces cytochrome P450 enzymes and can reduce the levels of divalproex and other medications.648”
In the citing paper
“Carbamazepine induces cytochrome P450 enzymes and can reduce the levels of divalproex and other medications.648”
In the citing paper
“Carbamazepine has been associated with hepatitis, serious blood dyscrasias, and cognitive changes.145”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [145]
In the citing paper
“Side effects of valproic acid and derivatives include sedation, gait disturbances, and tremor. Other risks include alopecia, thrombocytopenia, hyperammonemia, pancreatitis, liver injury, cognitive changes, and mortality.126 145”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [145]
Citations
Cites
Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression
Goodwin, F. K., & Jamison, K. R. (2007) · Medical Entomology and Zoology · Cited by 1,325
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Manjunath, G., Tighiouart, H., Ibrahim, H., MacLeod, B., Salem, D. N., Griffith, J. L., Coresh, J., Levey, A. S., & Sarnak, M. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02663-3 · Cited by 920
Bowden, C. L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.481 · Cited by 678 · cited 1×
“Nausea, vomiting, and diarrhea are common, although generally transient, side effects of lithium and VPA (Bowden et al., 1994, 2000), occurring in up to 50% of patients.”
BackgroundValproic Acid Monotherapy in Pregnancy and Major Congenital Malformations
Jentink, J., Loane, M. A., Dolk, H., Barisic, I., Garne, E., Morris, J. K., & de Jong-van den Berg, L. T. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907328 · Cited by 587
Predictors of Noncompliance in Patients With Schizophrenia
Perkins, D. O. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1206 · Cited by 544
Lithium toxicity profi le: a systematic review and meta-analysis
McKnight, R. F., Budge, K., Ba, S., Goodwin, G. M., Geddes, J. R., & Adida, M. (2012) · Cited by 544
A Reevaluation of Risk of In Utero Exposure to Lithium
Cohen, L. S. (1994) · JAMA · doi:10.1001/jama.1994.03510260078033 · Cited by 475
Pattern of Malformations in the Children of Women Treated with Carbamazepine during Pregnancy
Jones, K. L., Lacro, R. V., Johnson, K. A., & Adams, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906223202505 · Cited by 447
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.770551 · Cited by 421
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Assessment and management of behavioral and psychological symptoms of dementia
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ · doi:10.1136/bmj.h369 · Cited by 1,247
Montejo, A. L., Montejo, L., & Baldwin, D. S. (2018) · World Psychiatry · doi:10.1002/wps.20509 · Cited by 189
Simonetti, A., Pais, C., Jones, M. B., Cipriani, M. C., Janiri, D., Monti, L., Landi, F., Bernabei, R., Liperoti, R., & Sani, G. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.579842 · Cited by 154
Hayes, J., Marston, L., Walters, K. R., Geddes, J. R., King, M., & Osborn, D. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002058 · Cited by 129
“Valproate has been found to be associated with a high risk of asymptomatic elevated transaminases and can cause idiosyncratic hepatic failure [15,18].”
BackgroundManaging Behavioral and Psychological Symptoms of Dementia
Gerlach, L. B., & Kales, H. C. (2017) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2017.10.010 · Cited by 107
Gorman, D. A., Gardner, D. M., Murphy, A. L., Feldman, M., Bélanger, S. A., Steele, M. M., Boylan, K., Cochrane-Brink, K., Goldade, R., Soper, P. R., et al. (2015) · The Canadian Journal of Psychiatry · doi:10.1177/070674371506000204 · Cited by 118
Lithium in the Kidney: Friend and Foe?
Alsady, M., Baumgarten, R., Deen, P. M. T., & de Groot, T. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015080907 · Cited by 100
Bipolar Disorder and ADHD: Comorbidity and Diagnostic Distinctions
Marangoni, C., Chiara, L. D., & Faedda, G. L. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0604-y · Cited by 95
Podocyte GSK3 is an evolutionarily conserved critical regulator of kidney function
Hurcombe, J., Hartley, P. S., Lay, A. C., Ni, L., Bedford, J. J., Leader, J. P., Singh, S., Murphy, A. J., Scudamore, C. L., Márquez, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08235-1 · Cited by 75
Old Age Bipolar Disorder—Epidemiology, Aetiology and Treatment
Arnold, I., Dehning, J., Grunze, A., & Hausmann, A. (2021) · Medicina · doi:10.3390/medicina57060587 · Cited by 85
Using Lithium in Older Age Bipolar Disorder: Special Considerations
Soh, J. F., Klil‐Drori, S., & Rej, S. (2019) · Drugs & Aging · doi:10.1007/s40266-018-0628-1 · Cited by 62
Bipolar depression: a review of treatment options
Levenberg, K., & Cordner, Z. A. (2022) · General Psychiatry · doi:10.1136/gpsych-2022-100760 · Cited by 68
“26 Especially long-term use is associated with thyroid dysfunction, 27 with approximately 20% of patients eventually developing hypothyroidism and 9% experiencing hyperparathyroidism.”
BackgroundTreatment of behavioral and psychological symptoms of dementia: a systematic review
Preuss, U. W., Wong, J., & Koller, G. (2016) · Psychiatria Polska · doi:10.12740/pp/64477 · Cited by 74
“Olin [96] 2001 Carbamazepine in Alzheimer’s disease Anticonvulsants 2a Modest clinical benefit in carbamazepine treatment”
BackgroundResultRej, S., Yu, C., Shulman, K. I., Herrmann, N., Fischer, H. D., Fung, K., & Gruneir, A. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.07.001 · Cited by 52
“Valproate has been linked to thrombocytopenia and hepatic dysfunction [5].”
BackgroundLopes-Borges, J., Valvassori, S. S., Varela, R. B., Tonin, P. T., Vieira, J. S., Gonçalves, C. L., STRECK, E. L., & Quevedo, J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.11.014 · Cited by 48
The Lithium Battery: assessing the neurocognitive profile of lithium in bipolar disorder
Malhi, G. S., McAulay, C., Gershon, S., Gessler, D., Fritz, K., Das, P., & Outhred, T. (2016) · Bipolar Disorders · doi:10.1111/bdi.12375 · Cited by 50
Dols, A., & Beekman, A. T. F. (2017) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2017.10.008 · Cited by 44
“Because side effects are among the most important reasons for patients to stop taking their medication, careful investigation and management of these side effects is advised.(64)”
Self-citationManaging Behavioral and Psychological Symptoms of Dementia
Gerlach, L. B., & Kales, H. C. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.11.010 · Cited by 45
Update on the Epidemiology, Diagnosis, and Treatment of Mania in Older-Age Bipolar Disorder
Chen, P., Dols, A., Rej, S., & Sajatovic, M. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0804-8 · Cited by 41
Self-citationC-reactive protein and cardiovascular risk in bipolar disorder patients: A systematic review
Marshe, V. S., Pira, S., Mantere, O., Bosche, B., Looper, K. J., Herrmann, N., Müller, D. J., & Rej, S. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.026 · Cited by 40
Dols, A., & Beekman, A. T. F. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.11.008 · Cited by 35
Self-citationMolecular Signatures of Lithium Treatment: Current Knowledge
Bellivier, F., & Marie-Claire, C. (2018) · Pharmacopsychiatry · doi:10.1055/a-0650-4820 · Cited by 29
“A similar level of variability is also observed for the side effect profile of Li [6].”
BackgroundGivens, C. (2016) · Nursing Clinics of North America · doi:10.1016/j.cnur.2016.01.013 · Cited by 29
Elfeddali, I., Feltz-Cornelis, C. M. V. D., van Os, J., Knappe, S., Vieta, E., Wïttchen, H., Obradors‐Tarragó, C., & Haro, J. M. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph111010915 · Cited by 30
“These expectations indicate that the experts perceive addressing this challenge as an important first step towards solving important themes in the field of mental health, such as the economic and health-related burden caused by mental disorders [1,3,5,6] and the problem of side-effects of treatments, which form an imp…”
The role of xenobiotics in triggering psoriasis
Grželj, J., & Dolenc, M. S. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02870-8 · Cited by 29
Attitudes towards pharmacotherapy in late-life bipolar disorder
Rej, S., Schuurmans, J., Elie, D., Stek, M. L., Shulman, K., & Dols, A. (2016) · International Psychogeriatrics · doi:10.1017/s1041610215002380 · Cited by 23
Self-citationCariprazine in the Treatment of Bipolar Disorder: Within and Beyond Clinical Trials
Do, A., Keramatian, K., Schaffer, A., & Yatham, L. N. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.769897 · Cited by 23
“extrapyramidal symptoms, metabolic abnormalities and weight gain, which often leads to poor adherence (7, 8).”
BackgroundDiagnosis and Management of Bipolar Disorder in Primary Care
Brenner, C. J., & Shyn, S. I. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.06.004 · Cited by 24
Has Psychiatric Medication Reduced Crime and Delinquency?
Finkelhor, D., & Johnson, M. (2015) · Trauma Violence & Abuse · doi:10.1177/1524838015620817 · Cited by 20
“There is a substantial literature on this subject that cannot be summarized here (Almandil et al., 2013; Dols et al., 2013; Graham & Coghill, 2008; National Institute of Mental Health, 2012; Whiskey & Taylor, 2013).”
BackgroundŞengül, M. C. B., Karadağ, F., Şengül, C., Karakülah, K., Kalkancı, Ö., & Herken, H. (2014) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20140311041445 · Cited by 14
Psychopharmacological Considerations for Gender-Affirming Hormone Therapy
Kim, H.-H., Goetz, T. G., Grieve, V. L. B., & Keuroghlian, A. S. (2023) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000373 · Cited by 15
Liao, X., Ye, H., & Si, T. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s294521 · Cited by 15
“Apart from antipsychotics, mood stabilizers, such as lithium and antiepileptics, may also contribute towards increase in metabolic risks.(45) As mood stabilizers are often used as add-on therapy for patients with schizophrenia in the clinical practice,(46) combining antipsychotics with mood stabilizers seem to lead to…”
BackgroundKetogenic diet as a metabolic therapy for bipolar disorder: Clinical developments
Yu, B. J., Oz, R. S., & Sethi, S. (2022) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2022.100457 · Cited by 15
Nasr‐Esfahani, P., Nasiri, J., Badihian, S., & Yaghini, O. (2019) · Iranian journal of child neurology. · doi:10.22037/ijcn.v13i2.16652 · Cited by 11
“Skin rash is a rarely reported complication of VPA, mostly seen in combination therapies and is disappeared after drug discontinuation (4, 22).”
BackgroundInfluentialVincenzi, B., Greene, M. C., ULLOA, M., Parnarouskis, L., Jackson, J. W., & Henderson, D. C. (2016) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000149 · Cited by 11
Pediatric suicide: Review of a preventable tragedy
Greydanus, D. E., Nazeer, A., Qayyum, Z., Patel, D. R., Rausch, R., Hoang, L.-N., Miller, C., Chahin, S. S., Apple, R. W., Saha, G. K., et al. (2024) · Disease-a-Month · doi:10.1016/j.disamonth.2024.101725 · Cited by 13
Korkotian, E., Botalova, A., Одегова, Т. Ф., Евгеньевна, Г. Е., Skryabina, E., & Segal, M. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.01.036 · Cited by 8
Rosenblat, J. D., & McIntyre, R. S. (2017) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0131-z · Cited by 10
Treatment-Resistant Depression
Cusin, C., & Peyda, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-97241-1_1 · Cited by 8
Psychedelic-assisted therapy for people with gambling disorder?
Romero, P., Czakó, A., van den Brink, W., & Demetrovics, Z. (2024) · Journal of Behavioral Addictions · doi:10.1556/2006.2024.00004 · Cited by 10
Farıdhosseını, F., Talaeı, A., Shahini, N., Salimi, Z., Eslamzadeh, M., Ahrari, S., Pourgholami, M., & Khadem‐Rezaiyan, M. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000454 · Cited by 8
“Considering many side effects caused by mood stabilizers (Dols et al., 2013), the marked incidence of metabolic syndromes in bipolar cases (Vancampfort et al.”
BackgroundLithium + Colchicine: A Potential Strategy to Reduce Pro-inflammatory Effects of Lithium Treatment
Mooney, J. J., & Brady, R. O. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000830 · Cited by 8
The effects of lithium on cognition in humans: A systematic review
Sabtiari, T. N., Myrtle, S., Orfanos, S., Young, A. H., & Strawbridge, R. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251371139 · Cited by 9
“However, defining an optimal lithium dose remains clinically challenging, as cognitive impairment may also result from other lith-ium-induced (and dose related) side effects, such as tremor, fatigue and polyuria, which can indirectly affect cognitive function (Dols et al., 2013).”
Lithium Response Variability: New Avenues and Hypotheses
Bellivier, F., & Marie-Claire, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-45923-3_9 · Cited by 5
van der Lee, A. P. M., Kupka, R., de Haan, L., & Beekman, A. T. F. (2021) · BJPsych Open · doi:10.1192/bjo.2021.994 · Cited by 5
Self-citationShort- and Midterm Side Effects of Lithium Therapy
McKnight, R. F., Geddes, J. R., & Goodwin, G. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45923-3_15 · Cited by 5
Putative biological predictors of treatment response in bipolar disorders
Gonzalez, S., Williams, A. J., Blacker, C. J., Voort, J. L. V., Schak, K. M., Nemeroff, C. B., Widge, A. S., & Tohen, M. F. (2016) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2016.11.003 · Cited by 6
Monitoring drug interventions in people with bipolar disorder
Zaidi, S., Heald, A. H., Belgamwar, R. B., & Fryer, A. A. (2023) · BMJ · doi:10.1136/bmj-2022-070678 · Cited by 3
Pampaloni, F., Ercis, M., Davis, D. M. R., Starace, M. V. R., Piraccini, B. M., Özerdem, A., Singh, B., Frye, M. A., Blacker, C. J., & Veldić, M. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.11.016 · Cited by 3
Kabzińska, K., Czajeczny, D., & Wójciak, R. W. (2021) · Health Psychology Report · doi:10.5114/hpr.2021.112090 · Cited by 7
“Furthermore, taking psychotropic drugs is often associated with side effects, e.g. headaches, drowsiness, libido disorders, difficulty in concentration, weight gain, and abdominal pain (Dols et al., 2013; Fung et al., 2019).”
BackgroundClinical Management of Older Age Bipolar Disorder
Dols, A., Chan, M. Y. S., & Shulman, K. I. (2017) · Springer eBooks · doi:10.1007/978-3-319-48912-4_4 · Cited by 3
Self-citationGenome-Wide Association Study of Lithium-Induced Dry Mouth in Bipolar I Disorder
Wu, L. S., Huang, M., Chen, C., Shen, C., Fann, C. S. J., Lin, C.-Y., Lin, C.-C., & Cheng, A. T. A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121265 · Cited by 3
“As a result, identification of the causes, including genetic predisposition leading to ADRs, as well as careful management and adequate education are imperative to ensure maximal lithium treatment adherence [14].”
BackgroundKetogenic diet as a metabolic therapy for bipolar disorder: Clinical developmentsPreprint
Yu, B. J., Ozveren, R., & Sethi, S. (2021) · Research Square · doi:10.21203/rs.3.rs-334453/v2 · Cited by 3
Bipolar (Manic-Depressive) Disorder
Tondo, L., & Baldessarini, R. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-097086-8.27008-6 · Cited by 3
Ketogenic diet as a metabolic therapy for bipolar disorder: Clinical developmentsPreprint
Yu, B. J., Ozveren, R., & Sethi, S. (2022) · Research Square · doi:10.21203/rs.3.rs-334453/v3 · Cited by 4
The Changing Care of Older Adults With Bipolar Disorder: A Narrative Analysis
Warner, A., Palmier‐Claus, J. E., Holland, C., Tyler, E., Rhodes, V., Settle, G., & Lobban, F. A. (2024) · Qualitative Health Research · doi:10.1177/10497323241263043 · Cited by 2
“Consequently, services should attempt to address the potential side effects of long-term medication use and other physical health challenges associated with ageing with bipolar disorder (Dols et al., 2013).”
Fulminant Hepatic Failure in the Context of Reinstituting Valproate Use
Rej, S., Chen, T., Edwards, M., & Zicherman, V. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.10.006 · Cited by 2
Safety and Tolerability of Mood Stabilisers
Fabrazzo, M., & Tortorella, A. A. V. (2015) · Springer eBooks · doi:10.1007/978-3-319-24741-0_11 · Cited by 2
Sadek, J. R. (2018) · Springer eBooks · doi:10.1007/978-3-319-45635-5_10 · Cited by 3
Efficacy of In Vitro Lithium Chloride Treatments on Dermacentor reticulatus
Kolics, B., Mátyás, K., Solti, I., Bacsi, Z., Kovács, S., Staszny, Á., Taller, J., & Kolics, É. (2023) · Insects · doi:10.3390/insects14020110 · Cited by 2
“It is also used in human medicine to treat bipolar disorder [41], although it is often associated with side effects at several times the range of trace amounts (~170 mg Li+/day) [42].”
BackgroundThe Treatment of the Dually Diagnosed: Intellectual Disability and Severe Psychopathology
McPherson, P., Colon, M. A., & Scott, H. (2020) · Autism and child psychopathology series · doi:10.1007/978-3-030-46835-4_29 · Cited by 2
The use of a low carbohydrate, ketogenic diet in bipolar disorder: systematic reviewPreprint
Yu, B. J., Ozveren, R., & Sethi, S. (2021) · Research Square · doi:10.21203/rs.3.rs-334453/v1 · Cited by 2
The Effects of Lithium Chloride Exposure on the Reproduction of Caenorhabditis elegans
Hatzis, G., Rossi, O., Testiler, I., Dobbins, G., & Homan, E. P. (2023) · PubMed Central · doi:10.17912/micropub.biology.000988 · Cited by 1
Lithium and Heart Block in an Adolescent Boy
Rice, T., Kufert, Y., Luber, M. J., & Coffey, B. J. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.29130.bjc · Cited by 1
“Common adverse effects of lithium include tremor, nausea, vomiting, diarrhea, weight gain, alopecia, hypothyroidism, and renal failure (Dols et al. 2013).”
Successful rechallenge following clozapine-induced adverse cutaneous reaction
Sarker, F., Plant, E., Oloyede, E., Mufti, F., Valsraj, K. M., & Whiskey, E. (2022) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2022.100042 · Cited by 1
Maroney, M. E., Liu, M. T., Smith, T. W., & Thomas, K. L. H. (2016) · Side effects of drugs annual · doi:10.1016/bs.seda.2016.07.014 · Cited by 2
Stevens, A. W. M. M. (2023) · doi:10.5463/thesis.366 · Cited by 1
Self-citationMeasurement of the Cerebellar Vermis in Bipolar Disorder and the Effect of Lithium Treatment
Mahnke, D. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/26850
Sadek, J. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-39794-8_6
Lithium in Older Age Bipolar Disorder
Rej, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-48912-4_7
Identifying the Complexity of Bipolar Disorder
Stiles, B. M. (2016) · IRL - University of Missouri, St. Louis (University of Missouri–St. Louis)
Approaches to Behavioral Problems in Dementia
Stripling, A. M. (2017) · NSUWorks (Nova Southeastern University)
Early, N. K., Fairman, K. A., Ma, J., & Hong, K. (2020) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2020.207 · Cited by 1
Norman, S. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.bipolar_overview
A Single Administration of GBR 12909 Alters Basal Mesocorticolimbic Activity
Galdino, L., Kunicki, A. C., Filho, L. C. N., Moioli, R. C., & de Araújo, M. F. P. (2022) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-030-70601-2_322
Almeida, O. P., Dols, A., & Sajatovic, M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108593946.012
Self-citationSmith, T. R., Liu, M. T., & Maroney, M. E. (2015) · Side effects of drugs annual · doi:10.1016/bs.seda.2015.05.005
Adverse Drug Reactions in the Bipolar Disorder Patients Treated With Mood Stabilizers
Jankar, B. B., Gosavi, D. D., Mishra, K. K., & Sathe, H. (2024) · Annals of Indian Psychiatry · doi:10.4103/aip.aip_171_22
Rana, A., Bamrah, P. K., Priyanak, & Gautam, H. (2024) · International Journal of Pharma Professional’s Research (IJPPR) · doi:10.69580/ijppr.15.3.2024.1-17
Stewart, T. (2024) · Springer eBooks · doi:10.1007/978-3-031-60894-0_7
Bipolar Disorder and Clinical Comorbidities
Palma, N., & Gomes, F. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-85519-1_12
Bipolar disorder isn’t the same for everyone. So people should have more say in how they’re treated
Parker, G. B., & Spoelma, M. J. (2023) · doi:10.64628/aa.u7nxnjwsu
Gut Microbiota: A Novel Perspective Linking Lithium Exposure to Epilepsy Risk
吴, 祺. (2025) · Bioprocess · doi:10.12677/bp.2025.154034
Case Report: Reversible myelodysplastic syndrome secondary to sodium valproate in an epileptic child
Huang, H., Chen, J., Ye, L., & Yu, D. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1828816
“The most common adverse reactions include weight gain, nausea, headache, dizziness, drowsiness, and ataxia (2, 4, 6).”
Lactation Failure in Postpartum Women Receiving a Dopamine Partial Agonist During Pregnancy
Parikh, P., Suthar, H. J., Shukla, A., Pansuriya, P., Bhatta, A. D., Singh, D., Alphonse, A. A., Kays, J., Chandra-Kaushik, A., Rodriguez, L., et al. (2026) · Annals of Clinical Psychiatry · doi:10.1177/10401237261494001
Metadata
- Authors
- Dols, A., Sienaert, P., van Gerven, H., Schouws, S., Stevens, A., Kupka, R., & Stek, M. L.
- Affiliations
- GGZ inGeest (NL)
- KU Leuven (BE)
- Dimence (NL)
- Corresponding author
- Dols, Annemiek
- Venue
- International Clinical Psychopharmacology
- Published
- 2013-11
- Volume
- 28
- Issue
- 6
- Pages
- 287-296
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2043524592
- Cited by
- 86
- References
- 120
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 5 · 2021: 8 · 2020: 6 · 2019: 4 · 2018: 5 · 2017: 11 · 2016: 12 · 2015: 10 · 2014: 5 · 2013: 1
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- bipolar disorder, mood stabilizers, lithium, antiepileptic drugs, valproic acid, carbamazepine, lamotrigine, adverse drug reactions, side effect management, dose reduction, medication adherence, elderly patients, renal excretion, hepatic metabolism, somatic comorbidity, teratogenicity, nephrogenic diabetes insipidus, thyroid dysfunction, hepatotoxicity, sexual dysfunction
- MeSH terms
- Anticonvulsants, Bipolar Disorder, Cognition Disorders, Gastrointestinal Diseases, Humans, Lithium, Prevalence, Antimanic Agents, Disease Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.